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The transcription factor Gata3 is crucial for the development of several tis-
sues and cell lineages both during development as well as postnatally.
This importance is apparent from the early embryonic lethality following
germline Gata3 deletion, with embryos displaying a number of phenotypes,
and from the fact that Gata3 has been implicated in several cancer types. It
often acts at the level of stem and progenitor cells in which it controls the
expression of key lineage-determining factors as well as cell cycle genes,
thus being one of the main drivers of cell fate choice and tissue morphogen-
esis. Gata3 is involved at various stages of haematopoiesis both in the adult
as well as during development. This review summarizes the various contri-
butions of Gata3 to haematopoiesis with a particular focus on the emergence
of the first haematopoietic stem cells in the embryo—a process that appears
to be influenced by Gata3 at various levels, thus highlighting the complex
nature of Gata3 action.1. Introduction
Haematopoiesis refers to the formation of blood cellular components. All these
components originate from multipotent haematopoietic stem cells (HSCs),
which form the foundation of this process. The system is traditionally seen as
hierarchical, with the multipotent HSC being the mother cell that gives rise
to and differentiates into multipotent and unipotent intermediate progenitor
cells, resulting in the production of functional mature blood cells, although in
recent years exceptions have been discovered that have an HSC-independent
origin (reviewed in [1]). As such, HSCs have unique characteristics that in com-
bination distinguish them from other more mature cells: (i) self-renewal ability;
(ii) high proliferation ability; (iii) long-term activity; and (iv) potential to differ-
entiate into all the different haematopoietic lineages. All these characteristics
make those cells the most clinically relevant cells for transplants.
Haematopoiesis is a complex and intricate process that is governed by a
large number of signalling pathways and transcription factors. The transcrip-
tion factors themselves are often organized in multi-gene families and play
essential roles in activating target genes of specific cell fates and in repressing
target genes of alternative cell fates. The GATA family of transcription factors
are such master regulators. This family has six members in vertebrates, and
the disruption of each of the Gata genes, with exception of Gata5, causes
embryonic lethality in mice. They are grouped into haematopoietic (Gata1,
Gata2, Gata3), and endodermal (Gata4, Gata5, Gata6) subgroups (recently
reviewed in [2]). Each GATA transcription factor is highly conserved across
vertebrates. For example, Gata3 homologues are found in human, mouse, rat,
chimpanzee, dog, chicken, frog and zebrafish. Gata3 shares 97% of its amino
acid identity between mouse and human. Within the GATA family, members
share varying degrees of homology. For example, while GATA2 and GATA3
are about 55% homologous at the amino acid level, GATA3 and GATA4 are
only 20% homologous.
rsob.royalsocietypublishing.org
Open
Biol.8:180152
2The largest degree of conservation is found in the zinc
finger domains, which are about 80% homologous among all
six members. The two zinc fingers bind to different sequences
and each has a unique function. The C-finger binds to the
GATA consensus site, WGATAR, although in a genome-wide
ChIP-seq experiment, Fujiwara et al. [3] reported that GATA
proteins preferred binding to WGATAA sequences in vivo.
However, the abundance of these motifs is such that the bind-
ing of GATA factors to specific DNA loci cannot be inferred
from the presence of the sequence alone. Instead, it has
become clear that occupancy of specific DNA sites by GATA
factors is dependent on the presence of other co-regulatory pro-
teins which can facilitate recruitment of GATA factors to
specific protein complexes or regulate GATA activity through
post-translational modifications (reviewed in [4]).
TheN-finger facilitates the interactionwith such co-regulat-
ory proteins, but can also bind specific, yet distinct, DNA
sequences [3,5–7]. This combination of DNA sequence-specific
binding and recruitment to chromatin via a dynamic range of
protein complexes resulting in both transcriptional activation
and repression allows GATA factors to participate in a large
repertoire of different processes that are highly cell context-
dependent. In the case of Gata3, this has been extensively
studied in lymphoid development, regulated by Gata3 at
various stages, which has recently been comprehensively
reviewed [8]. In addition, in a crystallographic structural
study by Bates et al. [9] for Gata3, it was observed that GATA
familymembers could bind to DNA by either homo- or hetero-
dimerizing, by forming a dimer with other GATA factors
through their two C-fingers.
All GATA factors have both distinct and common bio-
logical roles and biochemical characteristics, and all have a
restricted expression pattern, which is controlled by tissue-
specific enhancer elements. The regulatory elements that
control Gata3 expression have been well characterized through
the identification of enhancers that drive its expression in
the urogenital system, the central nervous system, the
endocardium and in natural killer (NK)/T-cells, with the
NK/T-cell-specific element being located 280 kb downstream
of theGata3 gene [10,11]. However, in some cases, the functions
of GATA factors are interchangeable [12]. For example, Gata1,
Gata2, Gata3 and Gata4 can activate interleukin-4 (Il4) and Il5
expression in T-cells, which are classically target genes for
Gata3, and repress the activation of interferon-g [13].Moreover,
a Gata3 knock-in can partially rescue erythrocyte defects in
Gata1 null mice; however, Gata3 cannot fully rescue the pheno-
type of Gata1 null mice, indicating that each GATA factor
maintains its unique functions [14,15].2. The three haematopoietic GATAs
While Gata4, Gata5 and Gata6 drive differentiation of meso-
derm- and endoderm-derived tissues and are therefore
critical for the development of heart and lung, the first three
members of the GATA family are involved in the differen-
tiation of mesoderm- and ectoderm-derived tissues and play
essential roles in the development and maintenance of the
haematopoietic system. Very broadly speaking, the main func-
tion of Gata1 is cell fate determination at an early branch point
in the haematopoietic tree, where it induces megakaryocyte
and erythrocyte development, while preventing granulocyte-
monocyte and lymphoid commitment. However, it is alsoexpressed further downstream in common lymphoid and
myeloid progenitors, mast cells and eosinophils [16,17]. The
most critical role of Gata2 is the formation and maintenance
of HSCs [18,19], although it has additional functions in specific
blood lineages as discussed below. Gata3 is crucial for the
development of several lymphoid lineages (reviewed in [8])
and early definite haematopoietic stem and progenitor cells
[20,21], which will be discussed further below.
The haematopoietic group within the GATA factors con-
trol each other’s expression during development in different
cells, and are capable of functioning consecutively during
cell specification and lineage commitment in a process
called a GATA switch. GATA switch refers to instances
where one GATA factor is replaced by another GATA at the
chromatin site. GATA switches occur at many functionally
critical loci during development, including those that control
the expression of regulators of haematopoiesis, such as Gata2
itself [22]. Gata2 is a direct target of Gata1; however, in the
absence of Gata1, it can bind to a target region upstream of
its own promoter, which activates transcription and induces
histone acetylation. However, when Gata1 is expressed,
Gata2 is displaced by Gata1 at its chromatin site, which
activates erythropoiesis [23,24] (and reviewed in [4,22]).
2.1. Gata1
The essential role of Gata1 in erythropoiesis was demonstrated
in Gata1-deficient mice which suffer from early embryonic
death (E10.5–11.5) and an inablility to complete primitive
and definitive erythroid differentiation [25,26]. Gata1 is
expressed in HSCs and common myeloid and/or lymphoid
progenitors. It is also crucial for the development of the
megakaryocyte lineage [27] and for the survival of erythrocyte
precursors [28,29]. Gata1 downregulates cofactors that are
necessary for granulocyte–monocyte and lymphoid develop-
ment, including Spi1 (PU.1), Il7 and Pax5 [30,31], while
promoting megakaryocyte and erythrocyte commitment.
Gata1 is also expressed in eosinophils and mast cells, where
it plays a role in their terminal differentiation [16,17]. Function-
ally, Gata1 is involved in cell cycle regulation. In the context of
erythroid maturation, it was shown to induce G1 arrest by tar-
geting a number of key cell cycle regulators, which allows the
cells to undergo maturation, driven by a Gata1-dependent
erythroid gene expression programme [32].
2.2. Gata2
Gata2 is a master regulator of haematopoiesis. It is expressed in
HSCs, multipotent haematopoietic progenitors, megakaryo-
cytes, erythroid precursors, eosinophils and mast cells. Its
deletion leads to embryonic death at E10.5 and a complete dis-
ruption of definitive haematopoiesis [33]. This is at the level of
HSCs, as Gata2 is required for their emergence (as discussed
further below) and their subsequent survival in a dose-
dependent fashion [18,19,34]. However, while Gata2 is required
for the proliferation and survival of multipotent haematopoietic
progenitors and mast cell formation, it is dispensable for the
terminal differentiation of erythroid cells andmacrophages [35].
2.3. Gata3
Gata3 has been extensively studied in the context of innate
and adaptive lymphoid development, where it regulates
Table 1. Tissue-specific functions of Gata3.
system function reference
skin and hair generation of skin selective
barrier
promotion of progenitor
differentiation in the hair
follicle and proper hair
structure
[62–64]
kidney nephric duct development [65,66]
fat inhibition of adipocyte
differentiation
[67]
inner ear cochlea morphology [68]
mammary gland mammary gland morphology [69,70]
haematopoietic
system
T-cell development
Th2 commitment
ILCs
NK subsets
Cell cycle regulation in adult
HSCs
non-cell autonomous role in
embryonic HSC production
[36]
[39]
[43–45]
[46–48]
[56,58]
[20]
SNS essential for the production
of catecholamines
promotes survival of sympathetic
neurons in both adults and
embryos
[71,72]
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3differentiation and cell fate determination at various levels
(for an extensive recent review see [8]). Specifically, it was
found to be essential for the development, maintenance, sur-
vival and proliferation of early T-cell progenitors, as ES cells
with a deleted Gata3 gene were able to contribute to the
B-cell, myelomonocytic and erythroid lineages but not thy-
mocytic or T-cell lineages in chimera studies [36]. It was
subsequently demonstrated that Gata3 is required to induce
and seal the T-cell fate in early lymphoid progenitors, while
repressing the B lymphoid programme [37,38]. Within the
T-cell lineage, Gata3 is a master regulator of T helper type 2
cells (Th2). It regulates the differentiation of Th2 cells by con-
trolling genes that encode Th2 cytokines Il4, Il5 and Il13 [39].
It appears, however, that Gata3 levels need to be carefully
controlled throughout thymocyte development as levels
that are too high are cytotoxic, and levels that are too low
cause developmental failure [40]. Indeed, enforced expression
of Gata3 in the T-cell lineage caused a maturation arrest in the
cytotoxic T-cell lineage and promoted the formation of
thymic lymphoblastoid tumours [41], and overexpression
of Gata3 at early fetal thymocyte stages redirected their
differentiation towards the mast cell lineage [42].
Within the branch of innate immunity, Gata3 is central to
the development of the recently discovered innate lymphoid
cells (ILCs), especially the ILC2 lineage [43,44], a subset of
ILC3 cells [45] and a subset of ILC1-derived, tissue-resident
NK cells [46,47]. Thus, Gata3 is not necessary for the develop-
ment of classic (NK) cells, but is crucial for a specialized
subset of them. It is important for the terminal differentiation
of NK cells and their exit from the bone marrow, and is
crucial for the maintenance of liver-resident NK cells [48].
The importance of GATA3 in lymphoid development and
function is further highlighted by the fact that GATA3 has
also been implicated in T-cell acute lymphoblastic leukaemia
(T-ALL). Together, T-cell acute lymphocytic leukaemia 1
(TAL1), RUNX1 and GATA3 form a positive interconnected
auto-regulatory loop that directly activates theMYB oncogene,
thus reinforcing and stabilizing the oncogenic programme that
contributes to malignant transformation [49]. In addition,
whole genome sequencing of patients with early T-cell precur-
sor acute lymphoblastic leukaemia (ETP-ALL), an aggressive
subtype of T-ALL, has revealed GATA3 inactivating lesions
disrupting haematopoietic development [50]. GATA3 has
also been linked to other types of lymphoid malignancies. In
a genomic profiling study, a GATA3 single-nucleotide poly-
morphism genotype has been identified in a subtype of
childhood acute lymphoblastic leukaemia (ALL), Philadelphia
chromosome-positive ALL (Ph-like ALL), that has been associ-
ated with early treatment response, higher risk of relapse and
overall poor prognosis [51]. And in anaplastic large cell lym-
phoma, the absence of the GATA3 protein in addition to the
presence of suppressive histone (H3K27) trimethylation at the
GATA3 promoter suggests epigenetic regulation of GATA3 as
a mechanism involved in disease pathogenesis [52].
Gata3 is also highly expressed in the long-term repopulating
HSC (LT-HSC) population [53–55]. Using Gata3-null mice
(deleted postnatally with Mx1-Cre), Ku et al. [56] have shown
that Gata3 deletion results in the production of lower numbers
of adult LT-HSCs, and that a lower number of these Gata3-
deficient LT-HSCs are in cycle. This suggests that Gata3 is
necessary for maintaining normal numbers of LT-HSCs, and
that it regulates their entry into the cell cycle. However, by
using a conditional Gata3 knockout mouse line crossed to aVav-Cre line, Buza-Vidas et al. [57] have shown that deletion
of Gata3 from HSCs after their emergence in the embryo does
not affect the ability of HSCs to expand normally and that
their numbers remain unaffected in the bone marrow after
birth. Moreover, they reported that Gata3 deletion does not
affect the ability of HSCs to self-renew [57].
More recently, Frelin et al. [58] published data suggesting
that Gata3 controls the balance of LT-HSC self-renewal and
differentiation by regulating their reprogramming from LT-
HSC to intermediate term HSCs (IT-HSC). IT-HSCs are
important for maintaining blood counts at steady state. They
differ from LT-HSCs in that they are able to generate myeloid
and erythroid progeny for 12 weeks [53,54,59], are more abun-
dant than LT-HSCs (three times higher) [53,60], are more
proliferative, and exit the quiescent state of the cell cycle
more frequently than LT-HSCs: every 10–20 days compared
to 50–100 days in LT-HSCs [61]. However, the precise function
of Gata3 in adult HSCs requires further investigation.3. Gata3 in development
Gata3 plays a major role in cell lineage specification and
development in a variety of cells, tissues and organs during
embryogenesis (table 1), including adipocytes [67], kidney
[65], mammary gland [69], skin [62,73] and sympathetic
nervous system (SNS) [63,71,74]. Not only does the study of
rsob.royalsocietypublishing.org
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4Gata3 activity in these different systems provide uswith impor-
tant clues about the molecular details of Gata3 function, it has
also demonstrated that due to the close proximity of developing
systems in the embryo, Gata3 action in one tissue can influence
the development of a neighbouring tissue [20].
3.1. Skin and hair
Gata3 is essential for stem cell lineage determination in the skin.
It is expressed at the onset of inner root sheath (IRS) cell speci-
fication in hair follicles. When Gata3 was deleted using a LacZ
knock-in, IRS progenitors failed to differentiate to form IRS,
leading to the production of a defective hair structure [73]. In
addition, Gata3 is the most highly expressed member of the
GATA family in the interfollicular epidermis. The specific del-
etion of Gata3 from the epidermal layer, using a keratin-14-Cre
(K14-Cre) mouse line, proved to be prenatally lethal due to
impairment of the skin selective barrier. Those mice showed
defects in skin differentiation, abnormal hair follicle organiz-
ation and delayed hair growth and maintenance. Genomic
analysis of the mice revealed defective lipid biosynthesis. This
could be attributed to the loss of lipid acetyltransferase gene
(Agpat5), a gene that is a direct target of Gata3 [62,64]. Interest-
ingly, Gata3 has previously been linked to adipogenesis where
it was shown to inhibit adipocyte differentiation [67].
3.2. Kidney
Gata3 is the only GATA factor that is expressed in the urogen-
ital system prior to E12.5. It is necessary for the normal
development of the nephric duct. Using a HoxB7-Cre trans-
genic line, Grote et al. [65,66] specifically deleted Gata3 from
the nephric duct, which resulted in severe abnormalities in
the urogenital system and revealed that Gata3 is required to
prevent ectopic metanephric kidney duct formation and pre-
mature cell differentiation. Additionally, it was reported that
Gata3 haploinsufficiency resulted in renal dysplasia.
Gata3 has also been implicated in clear cell renal cell carci-
noma (cc-RCC), the most common subtype of RCC. Cooper
et al. [75] uncovered that when Gata3 expression was downre-
gulated by promoter hypermethylation, it resulted in
decreased expression of type III TGF-b receptor (TbRIII),
which is a betaglycan protein with tumour suppressor features
[75].
3.3. Inner ear
Gata3 is widely expressed in several cell types during ear
development, including inner hair cells, outer hair cells as
well as supportive cells [76–78]. As a consequence, the
entire cochlea of the inner ear shows significant degeneration
in mice heterozygous forGata3,which leads to hearing loss [68].
This is mirrored in patients with HDR syndrome, who have
only one functional copy of GATA3 and who suffer from
hypoparathyroidism, deafness and renal defects [79,80].
3.4. Mammary gland
Gata3 is crucial formammary gland development. It is the tran-
scription factor with the highest expression in the mammary
epithelium as shown by genome-wide transcript analysis [70].
When Gata3 was specifically deleted from the mammary
epithelium at the onset of puberty, using the murinemammarytumour virus (MMTV) promoter-Cre recombinase (MMTV-
Cre), the mammary glands failed to develop terminal end
buds (TEBs), resulting in abnormal ductal structures [69,70].
Its crucial role in the mammary gland is supported by the
detection of GATA3 mutations in around 10% of human
breast cancers. While the range of somatic mutations is
varied, they cluster mainly in the highly conserved C-terminal
second zinc finger [81]. Data from in vitro and in vivo studies
suggest that GATA3 acts as a tumour suppressor gene. In a
murine luminal breast cancer model, the loss of Gata3 resulted
in tumour progression and tumour dissemination [82]. More
specifically, GATA3 expression was shown to inhibit breast
cancer growth and pulmonary metastasis by repressing
metastasis-associated genes such as ID1, ID3, KRTHB1, LY6E
and RARRES3 [83], and restoration of Gata3 expression in a
breast cancer mouse model induced breast cancer differen-
tiation and supressed its dissemination [82]. Moreover,
GATA3 was found to promote the expression of microRNA-
29b (miR-29b),which in turn inducesdifferentiation, suppresses
metastasis and changes the tumour microenvironment [84]. In
addition, low expression of GATA3 was associated with a
poor survival rate and more aggressive disease, whereas
GATA3-expressing breast cancer patients had a better progno-
sis, were less likely to relapse, and had a better overall
survival rate [85]. The involvement of GATA3 in breast cancer,
however, is complex as it was also shown to promote the
growth of oestrogen-responsive tumours through direct bind-
ing to and activation of the oestrogen receptor a (ERa) gene
[86].ERa-positive tumoursdisplayamoredifferentiatedpheno-
type and are generally less aggressive, which may be another
reason why GATA3 expression in breast cancer is associated
with a more favourable prognosis [87–89].
3.5. Sympathetic nervous system
Gata3 is essential for the development of the SNS
[63,71,72,74,90]. In fact, this is the reason why Gata3 deletion
is embryonically lethal at around E11.5. This lethality was
attributed to noradrenaline deficiency in the SNS and could
be pharmacologically rescued by feeding the mothers DOPS,
a synthetic catecholamine intermediate [63]. It was sub-
sequently confirmed that Gata3 is essential for the production
of catecholamines, the SNS mediators, through controlling the
expression of tyrosine hydroxylase, the enzyme required for cat-
echolamine synthesis. It also plays amajor role in the survival of
sympathetic neurons in both adults and embryos [71,72].4. Gata3 in haematopoietic stem cell
emergence
The process of HSC emergence is highly conserved in ver-
tebrates and is closely linked to vascular development
(reviewed in [91,92]). It has been most intensely studied in the
intra-embryonic aorta–gonad–mesonephros (AGM) region,
where the first directly transplantable HSCs emerge at E10.5
in the mouse [93,94]. Haematopoietic stem and progenitor
cell emergence involves activation of a haematopoietic tran-
scriptional programme in a subset of endothelial cells, termed
haemogenic endothelial cells, within the major arterial vessels
of the embryo, such as the dorsal aorta within the AGM
[95–97]. These haemogenic endothelial cells then undergo
major structural and morphological changes that allow them
SNS
MD
MD
Mes Mes
Ao
Ao
SNS
SNS *
*
Figure 1. Gata3 expression in the AGM region. Images show cryosections of Gata3þ/Lz [114] E11.5 embryos stained with X-Gal for b-galactosidase activity (blue)
and counterstained with Neutral Red. Ao, aorta; MD, mesonephric duct; Mes, mesenchyme; SNS, sympathetic nervous system; asterisks indicate Gata3 staining
underneath haematopoietic clusters; arrowheads point to individual Gata3-expressing endothelial cells.
rsob.royalsocietypublishing.org
Open
Biol.8:180152
5to round up and detach from the endothelium as haematopoie-
tic stem and progenitor cells. Localized production of de novo
blood cells can be detected in tissue sections as clusters of cells
co-expressing endothelial and haematopoietic markers that are
attached to the endothelium, and has recently been captured
by live imaging [98–100]. This endothelial-to-haematopoietic
transition (EHT) is acutely dependent on the transcription
factor Runx1 [101]. In its absence, haemogenic endothelial
cells undergo apoptosis [100], no intra-aortic clusters are formed
[102–104] and the generation of definitive haematopoietic
stem and progenitor cells is disrupted [105,106].
The recent development of an elegant ex vivo co-aggregation
explant culture system has revealed additional maturation
stages that haemogenic endothelial cells have to undergo
before they become fully functional HSCs [107–109]. There
are at least three intermediate states as haemogenic endothelial
cells mature first into pro-HSCs, then type I pre-HSCs and
eventually via type II pre-HSCs into adult-type HSCs that can
directly repopulate adult recipients. These stages can be distin-
guished temporally and through the sequential upregulation of
the haematopoiesis-associated cell surface markers CD41,
CD43 and CD45 [107].
A day after their emergence in the dorsal aorta and associ-
ated vitelline and umbilical arteries, HSCs are also detected
in the yolk sac and the placenta [93,110–112]. Their presence
in these tissues is only temporary as they eventually go on to
colonize the fetal liver which becomes the major haemato-
poietic organ in the embryo from E12.5 until birth when
HSCs relocate to the bone marrow.
Gata3 is expressed in the sites of intraembryonic haemato-
poietic cell generation in the mouse (AGM and its precursor,
the para-aortic splanchnopleura) [20,113] (figure 1), zebrafish
[115], chicken [116], human [117] and in Xenopus [118,119].
In the mouse embryo, Gata3 is expressed at low level at E8.5
in the splanchnic mesoderm [113]. However, by E11.5 Gata3
is expressed at high levels throughout the embryo. At this
stage,Gata3deletionwas embryonically lethal, death occurring
concomitantly with the onset of definitive haematopoiesis in
the fetal liver [21]. Gata3 knockout embryos were shown to
have growth retardation, along with severe deformities in
spinal cord and brain, massive internal haemorrhage, anaemia
and defective liver haematopoiesis, i.e. definitive haematopoi-
esis, suggesting that Gata3 is essential for the development
of various systems [21]. Yolk sac (YS) haematopoiesis wasnormal, which corresponds with the fact the Gata3 is not
expressed in the YS [113]. Specifically, in an in vitro culture
system, the colonies that resulted from the YS of Gata3 knock-
out embryos, compared to their wild-type and heterozygous
littermates, were normal, indicating the maintenance of primi-
tive erythropoiesis. However, the colony numbers from the
fetal liver of the knockout embryos were low compared to the
wild-type and heterozygous littermates, indicating that Gata3
disruption severely affects definitive haematopoiesis [21].4.1. The sympathetic nervous system as part of the
haematopoietic stem cell niche
The observation that definitive haematopoiesis is affected in
Gata32/2 embryos [21] and that Gata3 is expressed in the
AGM [113] (figure 1) suggested that Gata3 may also be
involved in HSC emergence. Furthermore, expression analyses
and sorting of specific cell populations followed by transplan-
tation into immunocompromised mice led to the proposal
that defined structures located ventrally to the dorsal aorta,
termed sub-aortic patches, contain HSCs and/or their precur-
sors and that these expressed Gata3 [113,120]. The cells in
these patches were also found to co-express Gata2.
Gata3 was also identified as a potential AGM haematopoi-
esis regulator in expression profiling studies [121]. This study
comprised three comparisons: (i) HSC containing region
(middle part of the dorsal aorta) versus a region without
HSCs (caudal and rostral part of the aorta); (ii) the microenvir-
onment of HSCs before and after their emergence, i.e. the aorta
with the immediate mesenchyme of E9–E10 versus E11; and
(iii) using Ly-6A GFP transgenic embryos, which express GFP
in all embryonic HSCs and their precursors, populations
enriched for HSCs (E11 Ly-6A GFPþ cells) or their precursors
(E9 Ly-6A GFPþ cells) were compared. Gata3was found to be
upregulated in two of the three comparisons (ii and iii), i.e. in
tissues surrounding the dorsal aorta specifically at the time
of HSC emergence in the AGM and in HSC-enriched
populations: E11 Ly-6A GFPþ cells.
A role for Gata3 in HSC production in the AGM was sub-
sequently confirmed [20]. Germline-deleted Gata32/2 AGMs
contained fewer Ly-6A-GFPþ aortic endothelial cells and
showed reduced intra-aortic cluster formation. Most impor-
tantly, HSC activity in transplantation assays was severely
Ao
Gata3 WT Gata3 KO
SNS MD
Figure 2. Gata2 expression in Gata3 wild-type (WT) and knockout (KO) AGMs. Images of in situ hybridization with a Gata2 riboprobe on cryosections from E11.5
Gata3þ/þ (left) and Gata32/2 [21] (right) embryos. Ao, aorta; MD, mesonephric duct; SNS, sympathetic nervous system.
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6reduced in Gata32/2 and Gata3þ/2 AGMs. Interestingly, trans-
plantation of Gata3-LacZþ and Gata3-Lacz2 AGM cells
clearly assigned repopulation activity to the Gata3-LacZ2
population, strongly suggesting that Gata3 is not expressed
in newly formed HSCs, but performs a non-cell autonomous
role via the AGM haematopoietic microenvironment [20].
Oneof the components of theAGMhaematopoieticmicroen-
vironment turned out to be the co-developing SNS. It had
previously been reported that the SNS plays a major role in the
mobilization [122,123] and proliferation [124] of adult HSCs.
The fact that Gata3 deletion affected both the SNS [63] as well
as HSC production [20] in the AGM suggested the intriguing
possibility that a functional interplay between the haematopoie-
tic system and SNS already occurred at the time when these
first develop during embryogenesis. Indeed, it was then
demonstrated that external provision of catecholamines to
Gata3-deficient embryos rescued the HSC defect, confirming
that Gata3 regulates HSC numbers through catecholamine pro-
duction [20]. This indicates that HSC emergence in the AGM
should be investigated as a part of a whole developmental pro-
cess that is influenced by neighbouring tissues [20,121]. It also
suggests that the previously described sub-aortic patches
[113,120] may, in fact, have been cells of the SNS as they are
known to co-express Gata3 and Gata2 [20,71] (figures 1 and 2).
This does not rule out, however, that there may be individual
Gata2andGata3 expressingmesenchymalHSCprecursors [125].
4.2. A role for Gata3 in haematopoietic stem
cell precursors
In addition to its role in the AGM HSC microenvironment
(via the SNS) described above, there is also evidence that
Gata3 may contribute to the specification of the definitive
haematopoietic lineage. Manaia et al. [113] analysed the
expression of Gata3 and Lmo2 in mouse embryonic develop-
ment to understand the mechanisms involved in the
generation of definitive HSCs. Interestingly, they found that
Gata3 and Lmo2 are expressed concomitantly in the caudal
embryonic mesoderm where haematopoietic cluster-bearing
vessels develop, suggesting an involvement in cell fate deter-
mination. Another observation of their study was that Gata3expression is restricted to sites involved in definitive haema-
topoiesis. Gata3 is expressed in the environment from which
intraembryonic precursors emerge, and in the developing
haematopoietic sites before their colonization. Gata3 was
expressed both in the thymic rudiment until the first migrants
arrived, and in the septum transversum before it gives rise to
the fetal liver. However, no CD45þ haematopoietic cells were
present within those sites at that developmental stage [113].
More recently, Gata3was also found to be upregulated in a
subset of E10.5 endothelial cells that express GFP under the
control of the Runx1 þ 23 enhancer element (23GFPþ) that
was described to mark haemogenic endothelial cells [97],
indicating a possible involvement in HSC and progenitor
generation. In addition, Gata3 expression increased upon
Notch1 signalling induction, which expands the haemogenic
endothelial population, and enhanced their haematopoietic
potential [126]. Indeed, we found Gata3 expression in individ-
ual endothelial cells, often in the vicinity of haematopoietic
clusters (figure 1); however, further studies are required
to determine if Gata3 plays a functional role in haemogenic
endothelium and the EHT.4.3. Gata3 expression in other compartments of the
embryonic haematopoietic stem cell
microenvironment
Gata3 expression is also found in individual cells in the subaor-
ticmesenchymeof theAGMregion (figure 1). Expression in this
stromal compartment is restricted to the ventral side of the
dorsal aorta, where HSCs are preferentially located [127]. In
fact, Gata3-expressing cells were often detected just underneath
intra-aortic haematopoietic cell clusters [20]. This mesenchymal
expression disappears after E12.5, when intraembryonic
clusters cease to be generated [113]. A number of known regu-
lators of HSC emergence are expressed in cells of the sub-aortic
ventralmesenchyme including Bmp4, Scf, Runx1, Bmper, Thpo
and Dlk1, demonstrating that this cell compartment forms an
important embryonic HSC niche [128–133]. Furthermore,
cells with mesenchymal stem/stromal cell potential have been
detected specifically in the AGM at the time of HSC emergence
MD
UGR
SNS
catecholamines
Mes
Ao
growth
factors
growthfactors
Figure 3. Gata3 involvement in AGM haematopoiesis. Schematic diagram of
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7[134]. The sub-aortic mesenchymal cell compartment, however,
is avery heterogeneous population, and it is currently unknown
which cells participate in the niche for emerging HSCs
andwhether this compartment contains andmayeven bemain-
tained by mesenchymal stem cells. It is also currently not clear
whether Gata3 plays an important role in the mesenchymal
stroma of the AGM.
Gata3 is expressed in one further cell compartment in the
AGM region, the mesonephric ducts within the urogenital
ridges (UGRs) [20] (figure 1). It was recently demonstrated
that UGRs do not contain HSCs or their precursors, but their
presence promotes HSC formation in the neighbouring aorta
in co-aggregation studies, indicating that UGRs also form
part of the HSC supportive microenvironment [133]. Yet,
while it has been established that Gata3 expression in the
UGRs is required for kidney development [65], it is currently
unknownwhether it promotes the production of HSC-suppor-
tive factors in these structures. However, the fact that Gata3 is
expressed in several different cell types in the AGM relevant to
haematopoiesis highlights its complex involvement in the
production of the first HSCs.a transverse section through an E11.5 AGM region, highlighting the cell com-
partments that express Gata3. Gata3-positive cells (green) are found within
the endothelial layer (yellow) of the dorsal aorta (Ao), in the mesonephric
duct (MD), within the subaortic mesenchyme (orange; Mes) and in the sym-
pathetic nervous system (SNS). Blood cells are shown in red. The light green
cell depicts the putative involvement of Gata3 in the endothelial-to-haema-
topoietic transition. Curly arrows illustrate contributions made by the different
components of the microenvironment to EHT/HSC support, of which only cat-
echolamines are currently known to be Gata3-dependent. UGR, urogenital
ridges.5. Concluding remarks
Gata3 is essential for the development of several types of cells,
organs and tissues (table 1), and its disruption during develop-
ment results in severe defects and impairment in those systems,
leading to embryonic death atmidgestation followinggermline
deletion [21]. Analysis of the phenotypes of Gata3 deletion in
these different systems has revealed that Gata3 is often
expressed in the stem and progenitor compartment where it
regulates cell fate determination and differentiation. In the
developing kidney [65,66] and preadipocytes [67], it seems to
prevent premature differentiation, whereas in skin [73] and
mammary gland [69] it promotes progenitor differentiation.
Overall, however, its function is to ensure correct tissue mor-
phogenesis. Considering this crucial function, it is therefore
not surprising that Gata3 has been implicated in a number of
different cancer types.
How Gata3 functions at the molecular level is not well
understood in many of these systems. One common under-
lying theme may be regulation of the cell cycle as has been
suggested for the role of Gata3 in adult HSCs [56,58]. Gata3
may allow tissue-specific progenitors to differentiate by block-
ing their cell cycle, and this may also be how haemogenic
endothelial cells can then undergo the morphological changes
as they become blood cells. However, it is also clear that Gata3
activates tissue-specific genes such as tyrosine hydroxylase in
the SNS and lipid acetyltransferase in the skin. Some of the
genes that Gata3 activates during metastasis may also be
relevant for the EHT.
GATA factors have often been observed in common com-
plexes and have been seen to cross-regulate each other, with
the GATA switch being such an example. Within the AGM,
Gata2 and Gata3 expression overlaps in several cell compart-
ments (figures 1 and 2) and they are both involved in HSC
production in the AGM, but the nature of their interaction
appears to be tissue-specific. Both are expressed in the urogen-
ital ridges, but while Gata3 is expressed specifically in the
mesonephric ducts, Gata2 expression is found in the tissue
directly surrounding the ducts. Interestingly, however, the
expression of Gata2 around the ducts disappears in Gata32/2embryos [20] (figure 2). Both have been detected in the haemo-
genic endothelium, but the deletion of Gata2 affects the
development of definitive haematopoietic stem and progenitor
cells much more severely, suggesting that it may act upstream
of Gata3 here or performs a much more crucial function in the
EHT. In the SNS, on the other hand, Gata3 is clearly upstream
of Gata2, as Gata2 expression in sympathoadrenal cells disap-
pears in Gata3-null embryos, while its expression in the aortic
endothelium remains [20] (figure 2).
Very little is currently known about the upstream regula-
tors of Gata3 in the different AGM cell compartments.
Phox2b is required for Gata3 expression in the SNS [71]. Con-
sidering the crucial roles of Gata2 and Runx1 in the EHT,
these two transcription factors may well be upstream of
Gata3 in haemogenic endothelial cells. In addition, Notch1
was shown to induce Gata3 in an embryonic stem cell
model of the EHT [126]. As Notch1 is also crucial for
HSC emergence in the AGM [135], it is likely that Gata3
dependence on Notch signalling is conserved in vivo.
Current data have shown that Gata3 plays several roles in
the embryonic and adult haematopoietic system. However,
the similarities and differences in these roles require further
dissection. For example, in development, Gata3 was shown
to regulate HSCs by means of controlling SNS development
and the secretion of HSC-supportive catecholamines [20];
however, its expression patterns in the HSC microenviron-
ment suggest a more complex role in haematopoietic stem
and progenitor cell regulation (figure 3). In the sub-aortic
mesenchymal compartment, Gata3 expression is restricted
to a few scattered cells on the ventral side. The fact that it
rsob.royalsocietypublishing.org
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8has been associated with the stem and progenitor compart-
ment in several tissues makes it tempting to speculate that
its expression marks mesenchymal stem cells. Dissecting its
function in each cell type and identifying its role in HSC pre-
cursors and the HSC regulatory microenvironment is an
intricate process and will require tissue-specific deletion.
In addition, the scarcity of these cells and the dynamic
nature of the developing embryo add more challenges to iden-
tifying the role of Gata3 in the emerging definitive
haematopoietic system. However, the availability of powerful
tools such as RNA-Seq, which can now be performed on a
single-cell level, will help to identify the genetic programme
of these individual cell types and contribute to a betterunderstanding of the nature and function of these cells and
how Gata3 may influence their function. It is, however, very
likely that the haematopoietic phenotype described in germ-
line-deleted Gata3-null embryos [20,21] is a compound
phenotype resulting from the effects of Gata3 deletion in the
various AGM cell types.Data accessibility. This article has no additional data.
Competing interests. We declare we have no competing interests.
Funding. Our Gata3-related work was supported by an Intermediate
Fellowship from the Kay Kendall Leukaemia Fund (K.O.) and by a
fellowship from the King Abdullah International Medical Research
Centre (KAIMRC), Ministry of National Guard (N.Z.).Biol.8:1801References 521. Dzierzak E, Bigas A. 2018 Blood development:
hematopoietic stem cell dependence and
independence. Cell Stem Cell 22, 639–651. (doi:10.
1016/j.stem.2018.04.015)
2. Lentjes MH, Niessen HE, Akiyama Y, de Bruine AP,
Melotte V, van Engeland M. 2016 The emerging
role of GATA transcription factors in development
and disease. Expert Rev. Mol. Med. 18, e3. (doi:10.
1017/erm.2016.2)
3. Fujiwara T, O’Geen H, Keles S, Blahnik K, Linnemann
AK, Kang YA, Choi K, Farnham PJ, Bresnick EH. 2009
Discovering hematopoietic mechanisms through
genome-wide analysis of GATA factor chromatin
occupancy. Mol. Cell 36, 667–681. (doi:10.1016/j.
molcel.2009.11.001)
4. Katsumura KR, Bresnick EH, Group GFM. 2017 The
GATA factor revolution in hematology. Blood 129,
2092–2102. (doi:10.1182/blood-2016-09-687871)
5. Martin DI, Orkin SH. 1990 Transcriptional activation
and DNA binding by the erythroid factor GF-1/NF-
E1/Eryf 1. Genes Dev. 4, 1886–1898. (doi:10.1101/
gad.4.11.1886)
6. Newton A, Mackay J, Crossley M. 2001 The N-
terminal zinc finger of the erythroid transcription
factor GATA-1 binds GATC motifs in DNA. J. Biol.
Chem. 276, 35 794–35 801. (doi:10.1074/jbc.
M106256200)
7. Trainor CD, Omichinski JG, Vandergon TL,
Gronenborn AM, Clore GM, Felsenfeld G. 1996 A
palindromic regulatory site within vertebrate GATA-1
promoters requires both zinc fingers of the GATA-1
DNA-binding domain for high-affinity interaction.
Mol. Cell Biol. 16, 2238–2247. (doi:10.1128/MCB.
16.5.2238)
8. Tindemans I, Serafini N, Di Santo JP, Hendriks RW.
2014 GATA-3 function in innate and adaptive
immunity. Immunity 41, 191–206. (doi:10.1016/j.
immuni.2014.06.006)
9. Bates DL, Chen Y, Kim G, Guo L, Chen L. 2008 Crystal
structures of multiple GATA zinc fingers bound to
DNA reveal new insights into DNA recognition and
self-association by GATA. J. Mol. Biol. 381,
1292–1306. (doi:10.1016/j.jmb.2008.06.072)
10. Hosoya-Ohmura S, Lin YH, Herrmann M, Kuroha T,
Rao A, Moriguchi T, Lim KC, Hosoya T, Engel JD.2011 An NK and T cell enhancer lies 280 kilobase
pairs 30 to the gata3 structural gene. Mol. Cell Biol.
31, 1894–1904. (doi:10.1128/MCB.05065-11)
11. Lakshmanan G, Lieuw KH, Lim KC, Gu Y, Grosveld F,
Engel JD, Karis A. 1999 Localization of distant
urogenital system-, central nervous system-, and
endocardium-specific transcriptional regulatory
elements in the GATA-3 locus. Mol. Cell Biol. 19,
1558–1568. (doi:10.1128/MCB.19.2.1558)
12. Burch JB. 2005 Regulation of GATA gene expression
during vertebrate development. Semin. Cell Dev. Biol.
16, 71–81. (doi:10.1016/j.semcdb.2004.10.002)
13. Ranganath S, Murphy KM. 2001 Structure and
specificity of GATA proteins in Th2 development.
Mol. Cell Biol. 21, 2716–2725. (doi:10.1128/MCB.
21.8.2716-2725.2001)
14. Takahashi S et al. 2000 GATA factor transgenes
under GATA-1 locus control rescue germline GATA-1
mutant deficiencies. Blood 96, 910–916.
15. Tsai FY, Browne CP, Orkin SH. 1998 Knock-in
mutation of transcription factor GATA-3 into the
GATA-1 locus: partial rescue of GATA-1 loss of
function in erythroid cells. Dev. Biol. 196, 218–227.
(doi:10.1006/dbio.1997.8842)
16. Harigae H et al. 1998 Differential roles of GATA-1
and GATA-2 in growth and differentiation of mast
cells. Genes Cells 3, 39–50. (doi:10.1046/j.1365-
2443.1998.00166.x)
17. Iwasaki H, Mizuno S, Wells RA, Cantor AB,
Watanabe S, Akashi K. 2003 GATA-1 converts
lymphoid and myelomonocytic progenitors into
the megakaryocyte/erythrocyte lineages. Immunity
19, 451–462. (doi:10.1016/S1074-
7613(03)00242-5)
18. de Pater E et al. 2013 Gata2 is required for HSC
generation and survival. J. Exp. Med. 210,
2843–2850. (doi:10.1084/jem.20130751)
19. Gao X, Johnson KD, Chang YI, Boyer ME, Dewey CN,
Zhang J, Bresnick EH. 2013 Gata2 cis-element is
required for hematopoietic stem cell generation in
the mammalian embryo. J. Exp. Med. 210,
2833–2842. (doi:10.1084/jem.20130733)
20. Fitch SR, Kimber GM, Wilson NK, Parker A,
Mirshekar-Syahkal B, Gottgens B, Medvinsky A,
Dzierzak E, Ottersbach K. 2012 Signaling from thesympathetic nervous system regulates
hematopoietic stem cell emergence during
embryogenesis. Cell Stem Cell 11, 554–566.
(doi:10.1016/j.stem.2012.07.002)
21. Pandolfi PP, Roth ME, Karis A, Leonard MW,
Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH.
1995 Targeted disruption of the GATA3 gene causes
severe abnormalities in the nervous system and in
fetal liver haematopoiesis. Nat. Genet. 11, 40–44.
(doi:10.1038/ng0995-40)
22. Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles
S. 2010 GATA switches as developmental drivers.
J. Biol. Chem. 285, 31 087–31 093. (doi:10.1074/
jbc.R110.159079)
23. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick
EH. 2003 GATA-1-dependent transcriptional
repression of GATA-2 via disruption of positive
autoregulation and domain-wide chromatin
remodeling. Proc. Natl Acad. Sci. USA 100,
8811–8816. (doi:10.1073/pnas.1432147100)
24. Suzuki M et al. 2013 GATA factor switching from
GATA2 to GATA1 contributes to erythroid
differentiation. Genes Cells 18, 921–933. (doi:10.
1111/gtc.12086)
25. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH.
1996 Arrested development of embryonic red cell
precursors in mouse embryos lacking transcription
factor GATA-1. Proc. Natl Acad. Sci. USA 93,
12 355–12 358. (doi:10.1073/pnas.93.22.12355)
26. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF,
D’Agati V, Orkin SH, Costantini F. 1991 Erythroid
differentiation in chimaeric mice blocked by a targeted
mutation in the gene for transcription factor GATA-1.
Nature 349, 257–260. (doi:10.1038/349257a0)
27. Chang AN, Cantor AB, Fujiwara Y, Lodish MB, Droho
S, Crispino JD, Orkin SH. 2002 GATA-factor
dependence of the multitype zinc-finger protein
FOG-1 for its essential role in megakaryopoiesis.
Proc. Natl Acad. Sci. USA 99, 9237–9242. (doi:10.
1073/pnas.142302099)
28. Chiba T, Nagata Y, Kishi A, Sakamaki K, Miyajima A,
Yamamoto M, Engel JD, Todokoro K. 1993 Induction
of erythroid-specific gene expression in lymphoid
cells. Proc. Natl Acad. Sci. USA 90, 11 593–11 597.
(doi:10.1073/pnas.90.24.11593)
rsob.royalsocietypublishing.org
Open
Biol.8:180152
929. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss
MJ. 1999 GATA-1 and erythropoietin cooperate to
promote erythroid cell survival by regulating bcl-xL
expression. Blood 94, 87–96.
30. Heavey B, Charalambous C, Cobaleda C, Busslinger
M. 2003 Myeloid lineage switch of Pax5 mutant but
not wild-type B cell progenitors by C/EBPa and
GATA factors. EMBO J. 22, 3887–3897. (doi:10.
1093/emboj/cdg380)
31. Nerlov C, Querfurth E, Kulessa H, Graf T. 2000 GATA-
1 interacts with the myeloid PU.1 transcription
factor and represses PU.1-dependent transcription.
Blood 95, 2543–2551.
32. Rylski M, Welch JJ, Chen YY, Letting DL, Diehl JA,
Chodosh LA, Blobel GA, Weiss MJ. 2003 GATA-1-
mediated proliferation arrest during erythroid
maturation. Mol. Cell Biol. 23, 5031–5042. (doi:10.
1128/MCB.23.14.5031-5042.2003)
33. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J,
Rosenblatt M, Alt FW, Orkin SH. 1994 An early
haematopoietic defect in mice lacking the
transcription factor GATA-2. Nature 371, 221–226.
(doi:10.1038/371221a0)
34. Ling KW, Ottersbach K, van Hamburg JP, Oziemlak
A, Tsai FY, Orkin SH, Ploemacher R, Hendriks RW,
Dzierzak E. 2004 GATA-2 plays two functionally
distinct roles during the ontogeny of hematopoietic
stem cells. J. Exp. Med. 200, 871–882. (doi:10.
1084/jem.20031556)
35. Tsai FY, Orkin SH. 1997 Transcription factor GATA-2
is required for proliferation/survival of early
hematopoietic cells and mast cell formation, but
not for erythroid and myeloid terminal
differentiation. Blood 89, 3636–3643.
36. Ting CN, Olson MC, Barton KP, Leiden JM. 1996
Transcription factor GATA-3 is required for
development of the T-cell lineage. Nature 384,
474–478. (doi:10.1038/384474a0)
37. Garcia-Ojeda ME, Klein Wolterink RG, Lemaitre F,
Richard-Le Goff O, Hasan M, Hendriks RW, Cumano
A, Di Santo JP. 2013 GATA-3 promotes T-cell
specification by repressing B-cell potential in pro-T
cells in mice. Blood 121, 1749–1759. (doi:10.1182/
blood-2012-06-440065)
38. Rothenberg EV. 2013 GATA-3 locks the door to the
B-cell option. Blood 121, 1673–1674. (doi:10.1182/
blood-2013-01-477737)
39. Lee GR, Fields PE, Flavell RA. 2001 Regulation of
IL-4 gene expression by distal regulatory elements
and GATA-3 at the chromatin level. Immunity 14,
447–459. (doi:10.1016/S1074-7613(01)00125-X)
40. Ho IC, Tai TS, Pai SY. 2009 GATA3 and the T-cell
lineage: essential functions before and after
T-helper-2-cell differentiation. Nat. Rev. Immunol. 9,
125–135. (doi:10.1038/nri2476)
41. Nawijn MC, Ferreira R, Dingjan GM, Kahre O, Drabek
D, Karis A, Grosveld F, Hendriks RW. 2001 Enforced
expression of GATA-3 during T cell development
inhibits maturation of CD8 single-positive cells and
induces thymic lymphoma in transgenic mice.
J. Immunol. 167, 715–723. (doi:10.4049/jimmunol.
167.2.715)42. Taghon T, Yui MA, Rothenberg EV. 2007 Mast cell
lineage diversion of T lineage precursors by the
essential T cell transcription factor GATA-3. Nat.
Immunol. 8, 845–855. (doi:10.1038/ni1486)
43. Hoyler T, Klose CS, Souabni A, Turqueti-Neves A,
Pfeifer D, Rawlins EL, Voehringer D, Busslinger M,
Diefenbach A. 2012 The transcription factor GATA-3
controls cell fate and maintenance of type 2 innate
lymphoid cells. Immunity 37, 634–648. (doi:10.
1016/j.immuni.2012.06.020)
44. Klein WRG, Serafini N, van Nimwegen M,
Vosshenrich CA, de Bruijn MJ, Fonseca Pereira D,
Veiga Fernandes H, Hendriks RW, Di Santo JP. 2013
Essential, dose-dependent role for the transcription
factor Gata3 in the development of IL-5þ and IL-
13þ type 2 innate lymphoid cells. Proc. Natl Acad.
Sci. USA 110, 10 240–10 245. (doi:10.1073/pnas.
1217158110)
45. Serafini N, Klein Wolterink RG, Satoh-Takayama N,
Xu W, Vosshenrich CA, Hendriks RW, Di Santo JP.
2014 Gata3 drives development of RORgtþ group 3
innate lymphoid cells. J. Exp. Med. 211, 199–208.
(doi:10.1084/jem.20131038)
46. Samson SI et al. 2003 GATA-3 promotes maturation,
IFN-g production, and liver-specific homing of NK
cells. Immunity 19, 701–711. (doi:10.1016/S1074-
7613(03)00294-2)
47. Vosshenrich CA et al. 2006 A thymic pathway of
mouse natural killer cell development characterized
by expression of GATA-3 and CD127. Nat. Immunol.
7, 1217–1224. (doi:10.1038/ni1395)
48. Ali AK, Oh JS, Vivier E, Busslinger M, Lee SH. 2016
NK cell-specific gata3 ablation identifies the
maturation program required for bone marrow exit
and control of proliferation. J. Immunol. 196,
1753–1767. (doi:10.4049/jimmunol.1501593)
49. Sanda T et al. 2012 Core transcriptional regulatory
circuit controlled by the TAL1 complex in human T
cell acute lymphoblastic leukemia. Cancer Cell 22,
209–221. (doi:10.1016/j.ccr.2012.06.007)
50. Zhang J et al. 2012 The genetic basis of early T-cell
precursor acute lymphoblastic leukaemia. Nature
481, 157–163. (doi:10.1038/nature10725)
51. Perez-Andreu V et al. 2013 Inherited GATA3 variants
are associated with pH-like childhood acute
lymphoblastic leukemia and risk of relapse. Nat.
Genet. 45, 1494–1498. (doi:10.1038/ng.2803)
52. Joosten M, Seitz V, Zimmermann K, Sommerfeld A,
Berg E, Lenze D, Leser U, Stein H, Hummel M. 2013
Histone acetylation and DNA demethylation of T
cells result in an anaplastic large cell lymphoma-like
phenotype. Haematologica 98, 247–254. (doi:10.
3324/haematol.2011.054619)
53. Benveniste P, Frelin C, Janmohamed S, Barbara M,
Herrington R, Hyam D, Iscove NN. 2010
Intermediate-term hematopoietic stem cells with
extended but time-limited reconstitution potential.
Cell Stem Cell 6, 48–58. (doi:10.1016/j.stem.2009.
11.014)
54. Kent DG et al. 2009 Prospective isolation and
molecular characterization of hematopoietic stem
cells with durable self-renewal potential. Blood113, 6342–6350. (doi:10.1182/blood-2008-12-
192054)
55. Zhong JF et al. 2005 Gene expression profile of
murine long-term reconstituting vs. short-term
reconstituting hematopoietic stem cells. Proc. Natl
Acad. Sci. USA 102, 2448–2453. (doi:10.1073/pnas.
0409459102)
56. Ku CJ, Hosoya T, Maillard I, Engel JD. 2012 GATA-3
regulates hematopoietic stem cell maintenance and
cell-cycle entry. Blood 119, 2242–2251. (doi:10.
1182/blood-2011-07-366070)
57. Buza-Vidas N, Duarte S, Luc S, Bouriez-Jones T, Woll
PS, Jacobsen SE. 2011 GATA3 is redundant for
maintenance and self-renewal of hematopoietic
stem cells. Blood 118, 1291–1293. (doi:10.1182/
blood-2011-02-338046)
58. Frelin C et al. 2013 GATA-3 regulates the self-
renewal of long-term hematopoietic stem cells. Nat.
Immunol. 14, 1037–1044. (doi:10.1038/ni.2692)
59. Dykstra B, Kent D, Bowie M, McCaffrey L, Hamilton
M, Lyons K, Lee SJ, Brinkman R, Eaves C. 2007
Long-term propagation of distinct hematopoietic
differentiation programs in vivo. Cell Stem Cell 1,
218–229. (doi:10.1016/j.stem.2007.05.015)
60. Foudi A, Hochedlinger K, Van Buren D, Schindler JW,
Jaenisch R, Carey V, Hock H. 2009 Analysis of
histone 2B-GFP retention reveals slowly cycling
hematopoietic stem cells. Nat. Biotechnol. 27,
84–90. (doi:10.1038/nbt.1517)
61. Wilson A et al. 2008 Hematopoietic stem cells
reversibly switch from dormancy to self-renewal
during homeostasis and repair. Cell 135,
1118–1129. (doi:10.1016/j.cell.2008.10.048)
62. Kurek D, Garinis GA, van Doorninck JH, van der
Wees J, Grosveld FG. 2007 Transcriptome and
phenotypic analysis reveals Gata3-dependent
signalling pathways in murine hair follicles.
Development 134, 261–272. (doi:10.1242/dev.
02721)
63. Lim KC, Lakshmanan G, Crawford SE, Gu Y, Grosveld
F, Engel JD. 2000 Gata3 loss leads to embryonic
lethality due to noradrenaline deficiency of the
sympathetic nervous system. Nat. Genet. 25,
209–212. (doi:10.1038/76080)
64. de Guzman Strong C et al. 2006 Lipid defect
underlies selective skin barrier impairment of an
epidermal-specific deletion of Gata-3. J. Cell Biol.
175, 661–670. (doi:10.1083/jcb.200605057)
65. Grote D, Souabni A, Busslinger M, Bouchard M.
2006 Pax 2/8-regulated Gata 3 expression is
necessary for morphogenesis and guidance of the
nephric duct in the developing kidney. Development
133, 53–61. (doi:10.1242/dev.02184)
66. Grote D, Boualia SK, Souabni A, Merkel C, Chi X,
Costantini F, Carroll T, Bouchard M. 2008 Gata3 acts
downstream of b-catenin signaling to prevent
ectopic metanephric kidney induction. PLoS Genet.
4, e1000316. (doi:10.1371/journal.pgen.1000316)
67. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM,
Hotamisligil GS. 2000 Function of GATA transcription
factors in preadipocyte-adipocyte transition. Science
290, 134–138. (doi:10.1126/science.290.5489.134)
rsob.royalsocietypublishing.org
Open
Biol.8:180152
1068. van der Wees J et al. 2004 Hearing loss following
Gata3 haploinsufficiency is caused by cochlear
disorder. Neurobiol Dis. 16, 169–178. (doi:10.1016/
j.nbd.2004.02.004)
69. Asselin-Labat ML et al. 2007 Gata-3 is an essential
regulator of mammary-gland morphogenesis and
luminal-cell differentiation. Nat. Cell Biol. 9,
201–209. (doi:10.1038/ncb1530)
70. Kouros-Mehr H, Werb Z. 2006 Candidate regulators
of mammary branching morphogenesis identified
by genome-wide transcript analysis. Dev. Dyn. 235,
3404–3412. (doi:10.1002/dvdy.20978)
71. Tsarovina K, Pattyn A, Stubbusch J, Muller F, van
der Wees J, Schneider C, Brunet JF, Rohrer H. 2004
Essential role of Gata transcription factors in
sympathetic neuron development. Development
131, 4775–4786. (doi:10.1242/dev.01370)
72. Tsarovina K, Reiff T, Stubbusch J, Kurek D, Grosveld
FG, Parlato R, Schutz G, Rohrer H. 2010 The Gata3
transcription factor is required for the survival of
embryonic and adult sympathetic neurons.
J. Neurosci. 30, 10 833–10 843. (doi:10.1523/
JNEUROSCI.0175-10.2010)
73. Kaufman CK, Zhou P, Pasolli HA, Rendl M, Bolotin
D, Lim KC, Dai X, Alegre ML, Fuchs E. 2003 GATA-3:
an unexpected regulator of cell lineage
determination in skin. Genes Dev. 17, 2108–2122.
(doi:10.1101/gad.1115203)
74. Moriguchi T et al. 2006 Gata3 participates in a
complex transcriptional feedback network to
regulate sympathoadrenal differentiation.
Development 133, 3871–3881. (doi:10.1242/dev.
02553)
75. Cooper SJ et al. 2010 Loss of type III transforming
growth factor-b receptor expression is due to
methylation silencing of the transcription factor
GATA3 in renal cell carcinoma. Oncogene 29,
2905–2915. (doi:10.1038/onc.2010.64)
76. Karis A, Pata I, van Doorninck JH, Grosveld F,
de Zeeuw CI, de Caprona D, Fritzsch B. 2001
Transcription factor GATA-3 alters pathway selection
of olivocochlear neurons and affects morphogenesis
of the ear. J. Comp. Neurol. 429, 615–630. (doi:10.
1002/1096-9861(20010122)429:4,615::AID-
CNE8.3.0.CO;2-F)
77. Lawoko-Kerali G, Rivolta MN, Holley M. 2002
Expression of the transcription factors GATA3 and
Pax2 during development of the mammalian inner
ear. J. Comp. Neurol. 442, 378–391. (doi:10.1002/
cne.10088)
78. Rivolta MN, Holley MC. 1998 GATA3 is
downregulated during hair cell differentiation in the
mouse cochlea. J. Neurocytol. 27, 637–647. (doi:10.
1023/A:1006951813063)
79. Muroya K et al. 2001 GATA3 abnormalities and the
phenotypic spectrum of HDR syndrome. J. Med.
Genet. 38, 374–380. (doi:10.1136/jmg.38.6.374)
80. Van Esch H et al. 2000 GATA3 haplo-insufficiency
causes human HDR syndrome. Nature 406,
419–422. (doi:10.1038/35019088)
81. Cancer Genome Atlas Network. 2012 Comprehensive
molecular portraits of human breast tumours.
Nature 490, 61–70. (doi:10.1038/nature11412)82. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage
LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z.
2008 GATA-3 links tumor differentiation and
dissemination in a luminal breast cancer model.
Cancer Cell 13, 141–152. (doi:10.1016/j.ccr.2008.
01.011)
83. Dydensborg AB, Rose AA, Wilson BJ, Grote D,
Paquet M, Giguere V, Siegel PM, Bouchard M. 2009
GATA3 inhibits breast cancer growth and pulmonary
breast cancer metastasis. Oncogene 28, 2634–2642.
(doi:10.1038/onc.2009.126)
84. Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z.
2013 GATA3 suppresses metastasis and modulates
the tumour microenvironment by regulating
microRNA-29b expression. Nat. Cell Biol. 15,
201–213. (doi:10.1038/ncb2672)
85. Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu
J, Carey LA, Perou CM. 2006 Estrogen-regulated
genes predict survival in hormone receptor-positive
breast cancers. J. Clin. Oncol. 24, 1656–1664.
(doi:10.1200/JCO.2005.03.2755)
86. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll
JS, Brown M. 2007 Positive cross-regulatory loop
ties GATA-3 to estrogen receptor a expression in
breast cancer. Cancer Res. 67, 6477–6483. (doi:10.
1158/0008-5472.CAN-07-0746)
87. Mehra R, Varambally S, Ding L, Shen R, Sabel MS,
Ghosh D, Chinnaiyan AM, Kleer CG. 2005
Identification of GATA3 as a breast cancer prognostic
marker by global gene expression meta-analysis.
Cancer Res. 65, 11 259–11 264. (doi:10.1158/0008-
5472.CAN-05-2495)
88. Parikh P, Palazzo JP, Rose LJ, Daskalakis C, Weigel
RJ. 2005 GATA-3 expression as a predictor of
hormone response in breast cancer. J. Am. Coll.
Surg. 200, 705–710. (doi:10.1016/j.jamcollsurg.
2004.12.025)
89. Sorlie T et al. 2001 Gene expression patterns of
breast carcinomas distinguish tumor subclasses with
clinical implications. Proc. Natl Acad. Sci. USA 98,
10 869–10 874. (doi:10.1073/pnas.191367098)
90. Hong SJ, Choi HJ, Hong S, Huh Y, Chae H, Kim KS.
2008 Transcription factor GATA-3 regulates the
transcriptional activity of dopamine b-hydroxylase
by interacting with Sp1 and AP4. Neurochem. Res.
33, 1821–1831. (doi:10.1007/s11064-008-9639-3)
91. Ciau-Uitz A, Monteiro R, Kirmizitas A, Patient R.
2014 Developmental hematopoiesis: ontogeny,
genetic programming and conservation. Exp.
Hematol. 42, 669–683. (doi:10.1016/j.exphem.
2014.06.001)
92. Medvinsky A, Rybtsov S, Taoudi S. 2011 Embryonic
origin of the adult hematopoietic system: advances
and questions. Development 138, 1017–1031.
(doi:10.1242/dev.040998)
93. Medvinsky A, Dzierzak E. 1996 Definitive
hematopoiesis is autonomously initiated by the
AGM region. Cell 86, 897–906. (doi:10.1016/S0092-
8674(00)80165-8)
94. Muller AM, Medvinsky A, Strouboulis J, Grosveld F,
Dzierzak E. 1994 Development of hematopoietic
stem cell activity in the mouse embryo. Immunity 1,
291–301. (doi:10.1016/1074-7613(94)90081-7)95. Li Y et al. 2014 Inflammatory signaling regulates
embryonic hematopoietic stem and progenitor cell
production. Genes Dev. 28, 2597–2612. (doi:10.
1101/gad.253302.114)
96. Solaimani KP et al. 2015 Whole-transcriptome
analysis of endothelial to hematopoietic stem cell
transition reveals a requirement for Gpr56 in HSC
generation. J. Exp. Med. 212, 93–106. (doi:10.
1084/jem.20140767)
97. Swiers G et al. 2013 Early dynamic fate changes in
haemogenic endothelium characterized at the
single-cell level. Nat. Commun. 4, 2924. (doi:10.
1038/ncomms3924)
98. Bertrand JY, Chi NC, Santoso B, Teng S, Stainier DY,
Traver D. 2010 Haematopoietic stem cells derive
directly from aortic endothelium during
development. Nature 464, 108–111. (doi:10.1038/
nature08738)
99. Boisset JC, van Cappellen W, Andrieu-Soler C,
Galjart N, Dzierzak E, Robin C. 2010 In vivo imaging
of haematopoietic cells emerging from the mouse
aortic endothelium. Nature 464, 116–120. (doi:10.
1038/nature08764)
100. Kissa K, Herbomel P. 2010 Blood stem cells emerge
from aortic endothelium by a novel type of cell
transition. Nature 464, 112–115. (doi:10.1038/
nature08761)
101. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck
NA. 2009 Runx1 is required for the endothelial to
haematopoietic cell transition but not thereafter.
Nature 457, 887–891. (doi:10.1038/nature07619)
102. Cai Z, de Bruijn M, Ma X, Dortland B, Luteijn T,
Downing RJ, Dzierzak E. 2000 Haploinsufficiency of
AML1 affects the temporal and spatial generation of
hematopoietic stem cells in the mouse embryo.
Immunity 13, 423–431. (doi:10.1016/S1074-
7613(00)00042-X)
103. North T, Gu TL, Stacy T, Wang Q, Howard L, Binder
M, Marin-Padilla M, Speck NA. 1999 Cbfa2 is
required for the formation of intra-aortic
hematopoietic clusters. Development 126,
2563–2575.
104. Yokomizo T, Dzierzak E. 2010 Three-dimensional
cartography of hematopoietic clusters in the
vasculature of whole mouse embryos. Development
137, 3651–3661. (doi:10.1242/dev.051094)
105. Okuda T, van Deursen J, Hiebert SW, Grosveld G,
Downing JR. 1996 AML1, the target of multiple
chromosomal translocations in human leukemia, is
essential for normal fetal liver hematopoiesis. Cell 84,
321–330. (doi:10.1016/S0092-8674(00)80986-1)
106. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe
AH, Speck NA. 1996 Disruption of the Cbfa2 gene
causes necrosis and hemorrhaging in the central
nervous system and blocks definitive hematopoiesis.
Proc. Natl Acad. Sci. USA 93, 3444–3449. (doi:10.
1073/pnas.93.8.3444)
107. Rybtsov S, Batsivari A, Bilotkach K, Paruzina D,
Senserrich J, Nerushev O, Medvinsky A. 2014 Tracing
the origin of the HSC hierarchy reveals an SCF-
dependent, IL-3-independent CD432 embryonic
precursor. Stem Cell Reports 3, 489–501. (doi:10.
1016/j.stemcr.2014.07.009)
rsob.royalsocietypublishing.org
Open
Biol.8:180152
11108. Rybtsov S et al. 2011 Hierarchical organization and
early hematopoietic specification of the developing
HSC lineage in the AGM region. J. Exp. Med. 208,
1305–1315. (doi:10.1084/jem.20102419)
109. Taoudi S, Gonneau C, Moore K, Sheridan JM,
Blackburn CC, Taylor E, Medvinsky A. 2008 Extensive
hematopoietic stem cell generation in the AGM
region via maturation of VE-CadherinþCD45þ pre-
definitive HSCs. Cell Stem Cell 3, 99–108. (doi:10.
1016/j.stem.2008.06.004)
110. de Bruijn MF, Speck NA, Peeters MC, Dzierzak E.
2000 Definitive hematopoietic stem cells first
develop within the major arterial regions of the
mouse embryo. EMBO J. 19, 2465–2474. (doi:10.
1093/emboj/19.11.2465)
111. Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK.
2005 The placenta is a niche for hematopoietic stem
cells. Dev. Cell 8, 365–375. (doi:10.1016/j.devcel.
2004.12.016)
112. Ottersbach K, Dzierzak E. 2005 The murine placenta
contains hematopoietic stem cells within the
vascular labyrinth region. Dev. Cell 8, 377–387.
(doi:10.1016/j.devcel.2005.02.001)
113. Manaia A, Lemarchandel V, Klaine M, Max-Audit I,
Romeo P, Dieterlen-Lievre F, Godin I. 2000 Lmo2
and GATA-3 associated expression in intraembryonic
hemogenic sites. Development 127, 643–653.
114. van Doorninck JH, van Der Wees J, Karis A,
Goedknegt E, Engel JD, Coesmans M, Rutteman M,
Grosveld F, De Zeeuw CI. 1999 GATA-3 is involved in
the development of serotonergic neurons in the
caudal raphe nuclei. J. Neurosci. 19, RC12. (doi:10.
1523/JNEUROSCI.19-12-j0002.1999)
115. Neave B, Rodaway A, Wilson SW, Patient R, Holder
N. 1995 Expression of zebrafish GATA 3 (gta3)
during gastrulation and neurulation suggests a role
in the specification of cell fate. Mech. Dev. 51,
169–182. (doi:10.1016/0925-4773(95)00351-7)
116. Leonard MW, Lim KC, Engel JD. 1993 Expression of
the chicken GATA factor family during early
erythroid development and differentiation.
Development 119, 519–531.
117. Labastie MC, Cortes F, Romeo PH, Dulac C, Peault B.
1998 Molecular identity of hematopoietic precursorcells emerging in the human embryo. Blood 92,
3624–3635.
118. Bertwistle D, Walmsley ME, Read EM, Pizzey JA,
Patient RK. 1996 GATA factors and the origins of
adult and embryonic blood in Xenopus: responses to
retinoic acid. Mech. Dev. 57, 199–214. (doi:10.
1016/0925-4773(96)00547-3)
119. Turpen JB, Kelley CM, Mead PE, Zon LI. 1997
Bipotential primitive-definitive hematopoietic
progenitors in the vertebrate embryo. Immunity
7, 325–334. (doi:10.1016/S1074-7613(00)80354-4)
120. Bertrand JY, Giroux S, Golub R, Klaine M, Jalil A,
Boucontet L, Godin I, Cumano A. 2005
Characterization of purified intraembryonic
hematopoietic stem cells as a tool to define their
site of origin. Proc. Natl Acad. Sci. USA 102,
134–139. (doi:10.1073/pnas.0402270102)
121. Mascarenhas MI, Parker A, Dzierzak E, Ottersbach K.
2009 Identification of novel regulators of
hematopoietic stem cell development through
refinement of stem cell localization and expression
profiling. Blood 114, 4645–4653. (doi:10.1182/
blood-2009-06-230037)
122. Katayama Y, Battista M, Kao WM, Hidalgo A,
Peired AJ, Thomas SA, Frenette PS. 2006
Signals from the sympathetic nervous system
regulate hematopoietic stem cell egress from bone
marrow. Cell 124, 407–421. (doi:10.1016/j.cell.
2005.10.041)
123. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS.
2008 Haematopoietic stem cell release is regulated
by circadian oscillations. Nature 452, 442–447.
(doi:10.1038/nature06685)
124. Spiegel A et al. 2007 Catecholaminergic
neurotransmitters regulate migration and
repopulation of immature human CD34þ cells
through Wnt signaling. Nat. Immunol. 8,
1123–1131. (doi:10.1038/ni1509)
125. Zovein AC et al. 2008 Fate tracing reveals the
endothelial origin of hematopoietic stem cells. Cell
Stem Cell 3, 625–636. (doi:10.1016/j.stem.2008.
09.018)
126. Jang IH et al. 2015 Notch1 acts via Foxc2 to
promote definitive hematopoiesis via effects onhemogenic endothelium. Blood 125, 1418–1426.
(doi:10.1182/blood-2014-04-568170)
127. Taoudi S, Medvinsky A. 2007 Functional
identification of the hematopoietic stem cell niche
in the ventral domain of the embryonic dorsal
aorta. Proc. Natl Acad. Sci. USA 104, 9399–9403.
(doi:10.1073/pnas.0700984104)
128. Durand C, Robin C, Bollerot K, Baron MH, Ottersbach K,
Dzierzak E. 2007 Embryonic stromal clones reveal
developmental regulators of definitive hematopoietic
stem cells. Proc. Natl Acad. Sci. USA 104, 20 838–20
843. (doi:10.1073/pnas.0706923105)
129. Mascarenhas MI, Bacon WA, Kapeni C, Fitch SR,
Kimber G, Cheng SW, Li J, Green AR, Ottersbach K.
2016 Analysis of Jak2 signaling reveals resistance of
mouse embryonic hematopoietic stem cells to
myeloproliferative disease mutation. Blood 127,
2298–2309. (doi:10.1182/blood-2015-08-664631)
130. McGarvey AC et al. 2017 A molecular roadmap of
the AGM region reveals BMPER as a novel regulator
of HSC maturation. J. Exp. Med. 214, 3731–3751.
(doi:10.1084/jem.20162012)
131. Mirshekar-Syahkal B et al. 2013 Dlk1 is a negative
regulator of emerging hematopoietic stem and
progenitor cells. Haematologica 98, 163–171.
(doi:10.3324/haematol.2012.070789)
132. Peeters M, Ottersbach K, Bollerot K, Orelio C, de Bruijn
M, Wijgerde M, Dzierzak E. 2009 Ventral embryonic
tissues and Hedgehog proteins induce early AGM
hematopoietic stem cell development. Development
136, 2613–2621. (doi:10.1242/dev.034728)
133. Souilhol C et al. 2016 Inductive interactions
mediated by interplay of asymmetric signalling
underlie development of adult haematopoietic stem
cells. Nat. Commun. 7, 10784. (doi:10.1038/
ncomms10784)
134. Mendes SC, Robin C, Dzierzak E. 2005 Mesenchymal
progenitor cells localize within hematopoietic sites
throughout ontogeny. Development 132,
1127–1136. (doi:10.1242/dev.01615)
135. Kumano K et al. 2003 Notch1 but not Notch2 is
essential for generating hematopoietic stem cells
from endothelial cells. Immunity 18, 699–711.
(doi:10.1016/S1074-7613(03)00117-1)
